glp-1 aesthetics news Survey: How Medications Are Changing Facial How to Navigate Facial Shifts

Artificial intelligence in ophthalmology: accuracy, challenges, and clinical application

Alogliptin monotherapy improves glycemic control in patients with type 2 diabetes

Antioxidant and anti-inflammatory action: The peptide modulates SOD (superoxide dismutase) and other antioxidant enzymes, reducing oxidative stress in damaged tissue

Relationship between beta-cell mass and diabetes onset

This could lead to reduced demand for snacks, sweets, sugary beverages, and other foods commonly associated with indulgence and comfort eating. Shift in Consumer Preferences As users of GLP-1 medications experience less hunger and eat smaller portions, they may shift towards more nutrient-dense foods that offer better satiety per calorie, like protein-rich foods, fruits, and vegetables

Both have distinct roles in supporting your body's resilience against oxidative stress